Toll Free: 1-888-928-9744
Published: Apr, 2014 | Pages:
23 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)
Laboratoires Thea S.A. - Product Pipeline Review - 2014 Summary Global Markets Direct's, 'Laboratoires Thea S.A. - Product Pipeline Review - 2014', provides an overview of the Laboratoires Thea S.A.'s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Laboratoires Thea S.A.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The report provides brief overview of Laboratoires Thea S.A. including business description, key information and facts, and its locations and subsidiaries - The report reviews current pipeline of Laboratoires Thea S.A.'s human therapeutic division and enlists all their major and minor projects - The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones - Special feature on out-licensed and partnered product portfolio - The report summarizes all the dormant and discontinued pipeline projects - Latest company statement - Latest news and deals relating to the Laboratoires Thea S.A.'s pipeline products Reasons to buy - Evaluate Laboratoires Thea S.A.'s strategic position with total access to detailed information on its product pipeline - Assess the growth potential of Laboratoires Thea S.A. in its therapy areas of focus - Identify new drug targets and therapeutic classes in the Laboratoires Thea S.A.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas - Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps - Develop strategic initiatives by understanding the focus areas of Laboratoires Thea S.A. and exploit collaboration and partnership opportunities - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Plan mergers and acquisitions effectively by identifying the most promising pipeline of Laboratoires Thea S.A. - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope - Explore the dormant and discontinued projects of Laboratoires Thea S.A. and identify potential opportunities in those areas - Avoid Intellectual Property Rights related issues
Table of Contents Table of Contents 2 List of Tables 3 List of Figures 3 Laboratoires Thea S.A. Snapshot 4 Laboratoires Thea S.A. Overview 4 Key Information 4 Key Facts 4 Laboratoires Thea S.A. - Research and Development Overview 5 Key Therapeutic Areas 5 Laboratoires Thea S.A. - Pipeline Review 7 Pipeline Products by Stage of Development 7 Pipeline Products - Monotherapy 8 Pipeline Products - Combination Treatment Modalities 9 Laboratoires Thea S.A. - Pipeline Products Glance 10 Laboratoires Thea S.A. - Late Stage Pipeline Products 10 Phase III Products/Combination Treatment Modalities 10 Laboratoires Thea S.A. - Clinical Stage Pipeline Products 11 Phase II Products/Combination Treatment Modalities 11 Laboratoires Thea S.A. - Drug Profiles 12 (lidocaine + phenylephrine + tropicamide) 12 Product Description 12 Mechanism of Action 12 R&D Progress 12 azithromycin 13 Product Description 13 Mechanism of Action 13 R&D Progress 13 T-1210 14 Product Description 14 Mechanism of Action 14 R&D Progress 14 Laboratoires Thea S.A. - Pipeline Analysis 15 Laboratoires Thea S.A. - Pipeline Products by Target 15 Laboratoires Thea S.A. - Pipeline Products by Route of Administration 16 Laboratoires Thea S.A. - Pipeline Products by Molecule Type 17 Laboratoires Thea S.A. - Pipeline Products by Mechanism of Action 18 Laboratoires Thea S.A. - Dormant Projects 19 Laboratoires Thea S.A. - Locations And Subsidiaries 20 Head Office 20 Other Locations & Subsidiaries 20 Appendix 22 Methodology 22 Coverage 22 Secondary Research 22 Primary Research 22 Expert Panel Validation 22 Contact Us 23 Disclaimer 23
List of Tables Laboratoires Thea S.A., Key Information 4 Laboratoires Thea S.A., Key Facts 4 Laboratoires Thea S.A. - Pipeline by Indication, 2014 6 Laboratoires Thea S.A. - Pipeline by Stage of Development, 2014 7 Laboratoires Thea S.A. - Monotherapy Products in Pipeline, 2014 8 Laboratoires Thea S.A. - Combination Treatment Modalities in Pipeline, 2014 9 Laboratoires Thea S.A. - Phase III, 2014 10 Laboratoires Thea S.A. - Phase II, 2014 11 Laboratoires Thea S.A. - Pipeline by Target, 2014 15 Laboratoires Thea S.A. - Pipeline by Route of Administration, 2014 16 Laboratoires Thea S.A. - Pipeline by Molecule Type, 2014 17 Laboratoires Thea S.A. - Pipeline Products by Mechanism of Action, 2014 18 Laboratoires Thea S.A. - Dormant Developmental Projects,2014 19 Laboratoires Thea S.A., Other Locations 20 Laboratoires Thea S.A., Subsidiaries 20
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.